On October 25, a symposium on the innovation and development of artificial intelligence and medical imaging medical devices was held in Beijing. The meeting exchanged information on the research and development and use of artificial intelligence and medical imaging products, focused on common problems of innovation and development, and discussed support policies.

The meeting concluded that artificial intelligence and medical imaging medical devices are representatives of the new quality productivity in the field of medical devices, and the sound support of the corresponding industrial innovation and development mechanism is an important initiative to implement the spirit of the Third Plenary Session of the 20th Party Congress and the reform requirements. The next step, the State Drug Administration will focus on research to crack the industrial development “blocking point” “difficult”, problem-oriented, strengthen inter-ministerial cooperation, further research targeted initiatives to accelerate the promotion of innovative products listed application, promote the corresponding industry innovation and high-quality development, better meet the public demand for medical devices. To better meet the public demand for medical devices.

Relevant ministries and commissions involved in the innovation and development of medical devices, relevant departments and bureaus of the State Drug Administration (SDA) and its subordinate units, medical institutions and scientific research institutes, medical device industry associations, Beijing Municipal and Shanghai Municipal Food and Drug Administration, as well as representatives of 12 enterprises and experts participated in the meeting.